{"id":20333,"date":"2020-03-21T13:02:48","date_gmt":"2020-03-21T12:02:48","guid":{"rendered":"http:\/\/redaktori.com\/?p=20333"},"modified":"2020-03-21T13:02:48","modified_gmt":"2020-03-21T12:02:48","slug":"curevac-vaksina-kunder-corones-e-mundur-ne-vjeshte","status":"publish","type":"post","link":"https:\/\/redaktori.com\/?p=20333","title":{"rendered":"CureVac: Vaksina kund\u00ebr Coron\u00ebs e mundur n\u00eb vjesht\u00eb"},"content":{"rendered":"

Nga vjeshta dhjet\u00ebra mij\u00ebra vet\u00eb mund t\u00eb marrin vaksin\u00ebn kund\u00ebr virusit Corona, sipas kreut t\u00eb firm\u00ebs bioteknologjike, CureVac n\u00eb Tybingen t\u00eb Gjermanis\u00eb, shkruan afp. Por ende ka pengesa.<\/strong><\/p>\n

\"CureVac<\/a><\/div>\n
\n
\n

Kreu i firm\u00ebs bioteknologjike gjermane n\u00eb Tybingen, CureVac, Franz Werner Haas ka b\u00ebr\u00eb t\u00eb ditur, se nga vjeshta \u00ebsht\u00eb i mundur furnizimi i dhjet\u00ebra mij\u00ebra vet\u00ebve me nj\u00eb vaksin\u00eb kund\u00ebr virusit Corona. T\u00eb dh\u00ebnat p\u00ebrkat\u00ebse p\u00ebr k\u00ebt\u00eb do t\u00eb jen\u00eb gati n\u00eb tremujorin e tret\u00eb t\u00eb vitit, tha Haas p\u00ebr revist\u00ebn gjermane \u201eWirtschaftwoche\u201d \u2013 Java Ekonomike. \u201eN\u00ebse t\u00eb dh\u00ebnat jan\u00eb t\u00eb mira, dhe autoritetet japin OK-in e tyre, at\u00ebher\u00eb mund t\u00eb fillojm\u00eb q\u00eb k\u00ebt\u00eb vit me nj\u00eb studim t\u00eb gjer\u00eb.\u201d Dhjet\u00ebra mij\u00ebra vet\u00eb mund t\u00eb marrin nd\u00ebrkoh\u00eb vaksin\u00ebn, tha Haas. \u201eN\u00ebse vaksina p\u00ebr mas\u00ebn e gjer\u00eb \u00ebsht\u00eb n\u00eb dispozicion k\u00ebt\u00eb vit apo n\u00eb vitin 2021, kjo varet nga konkluzionet e studimeve klinike dhe vendimi i autoriteteve p\u00ebrkat\u00ebse.\u201d<\/p>\n

\"Deutschland<\/a><\/div>\n
<\/p>\n
\"\"<\/div>\n

<\/ins><\/p>\n

\"\"<\/div>\n

<\/ins><\/p>\n

\"\"<\/div>\n

<\/ins><\/p>\n

<\/div>\n

<\/ins><\/p>\n

\"\"<\/div>\n

<\/ins><\/div>\n

N\u00eb nj\u00eb repart ekzistues mund t\u00eb prodhoheshin sipas tij \u201en\u00eb vit 200-400 milion\u00eb doza vaksine\u201d kund\u00ebr virusit Corona. Faza e par\u00eb e prodhimit nd\u00ebrkoh\u00eb ka filluar. CureVac, q\u00eb s\u00eb fundmi mori nga Bashkimi Europian 80 milion\u00eb euro mb\u00ebshtetje, k\u00ebrkon ta p\u00ebrdor\u00eb investimin e BE p\u00ebr zgjerimin e reparteve t\u00eb prodhimit. N\u00eb vitin 2022 zgjerimi i repartit mund t\u00eb jet\u00eb n\u00eb funksion. \u201cAty mund t\u00eb prodhojm\u00eb n\u00eb vit 1 miliard\u00eb doza vaksine dhe m\u00eb shum\u00eb kund\u00ebr virusit\u201d, tha Haas p\u00ebr gazet\u00ebn. Reparti mund t\u00eb p\u00ebrdoret edhe p\u00ebr prodhimin e vaksinave t\u00eb tjera, n\u00eb rast t\u00eb shp\u00ebrthimeve t\u00eb ngjashme t\u00eb epidemive.<\/p>\n

N\u00eb mes t\u00eb marsit u b\u00eb e ditur, se presidenti Donald Trump ishte p\u00ebrpjekur p\u00ebr t\u00eb siguruar ekskluzivisht p\u00ebr SHBA nj\u00eb vaksin\u00eb kund\u00ebr Coron\u00ebs me nj\u00eb shum\u00eb t\u00eb lart\u00eb financiare. Pas disa raportimeve n\u00eb media, firma deklaroi, se nuk ka pasur nj\u00eb p\u00ebrpjekje t\u00eb till\u00eb t\u00eb presidentit amerikan. DW<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nga vjeshta dhjet\u00ebra mij\u00ebra vet\u00eb mund t\u00eb marrin vaksin\u00ebn kund\u00ebr virusit Corona, sipas kreut t\u00eb firm\u00ebs bioteknologjike, CureVac n\u00eb Tybingen t\u00eb Gjermanis\u00eb, shkruan afp. Por ende ka pengesa. Kreu i firm\u00ebs bioteknologjike gjermane n\u00eb Tybingen, CureVac, Franz Werner Haas ka b\u00ebr\u00eb t\u00eb ditur, se nga vjeshta \u00ebsht\u00eb i mundur furnizimi i dhjet\u00ebra mij\u00ebra vet\u00ebve me […]<\/p>\n","protected":false},"author":1,"featured_media":20334,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"footnotes":""},"categories":[6,3,20,21],"tags":[],"yoast_head":"\nCureVac: Vaksina kund\u00ebr Coron\u00ebs e mundur n\u00eb vjesht\u00eb - Informohu qart\u00ebsisht!<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/redaktori.com\/?p=20333\" \/>\n<meta property=\"og:locale\" content=\"sq_AL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CureVac: Vaksina kund\u00ebr Coron\u00ebs e mundur n\u00eb vjesht\u00eb - Informohu qart\u00ebsisht!\" \/>\n<meta property=\"og:description\" content=\"Nga vjeshta dhjet\u00ebra mij\u00ebra vet\u00eb mund t\u00eb marrin vaksin\u00ebn kund\u00ebr virusit Corona, sipas kreut t\u00eb firm\u00ebs bioteknologjike, CureVac n\u00eb Tybingen t\u00eb Gjermanis\u00eb, shkruan afp. Por ende ka pengesa. Kreu i firm\u00ebs bioteknologjike gjermane n\u00eb Tybingen, CureVac, Franz Werner Haas ka b\u00ebr\u00eb t\u00eb ditur, se nga vjeshta \u00ebsht\u00eb i mundur furnizimi i dhjet\u00ebra mij\u00ebra vet\u00ebve me […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/redaktori.com\/?p=20333\" \/>\n<meta property=\"og:site_name\" content=\"Informohu qart\u00ebsisht!\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-21T12:02:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"892\" \/>\n\t<meta property=\"og:image:height\" content=\"501\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"http:\/\/redaktori.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"http:\/\/redaktori.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuta\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/redaktori.com\/?p=20333\",\"url\":\"https:\/\/redaktori.com\/?p=20333\",\"name\":\"CureVac: Vaksina kund\u00ebr Coron\u00ebs e mundur n\u00eb vjesht\u00eb - Informohu qart\u00ebsisht!\",\"isPartOf\":{\"@id\":\"https:\/\/redaktori.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/redaktori.com\/?p=20333#primaryimage\"},\"image\":{\"@id\":\"https:\/\/redaktori.com\/?p=20333#primaryimage\"},\"thumbnailUrl\":\"https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg\",\"datePublished\":\"2020-03-21T12:02:48+00:00\",\"dateModified\":\"2020-03-21T12:02:48+00:00\",\"author\":{\"@id\":\"https:\/\/redaktori.com\/#\/schema\/person\/470e9b98b348cb5da953e2daff276aa2\"},\"breadcrumb\":{\"@id\":\"https:\/\/redaktori.com\/?p=20333#breadcrumb\"},\"inLanguage\":\"sq\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/redaktori.com\/?p=20333\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sq\",\"@id\":\"https:\/\/redaktori.com\/?p=20333#primaryimage\",\"url\":\"https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg\",\"contentUrl\":\"https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg\",\"width\":892,\"height\":501,\"caption\":\"FILE PHOTO: An employee of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020. Picture taken on March 12, 2020. REUTERS\/Andreas Gebert\/File Photo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/redaktori.com\/?p=20333#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/redaktori.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CureVac: Vaksina kund\u00ebr Coron\u00ebs e mundur n\u00eb vjesht\u00eb\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/redaktori.com\/#website\",\"url\":\"https:\/\/redaktori.com\/\",\"name\":\"http:\/\/redaktori.com - Informohu qart\u00ebsisht!\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/redaktori.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sq\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/redaktori.com\/#\/schema\/person\/470e9b98b348cb5da953e2daff276aa2\",\"name\":\"http:\/\/redaktori.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sq\",\"@id\":\"https:\/\/redaktori.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5555287f41529e19277415e6cb9cfb4c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5555287f41529e19277415e6cb9cfb4c?s=96&d=mm&r=g\",\"caption\":\"http:\/\/redaktori.com\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CureVac: Vaksina kund\u00ebr Coron\u00ebs e mundur n\u00eb vjesht\u00eb - Informohu qart\u00ebsisht!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/redaktori.com\/?p=20333","og_locale":"sq_AL","og_type":"article","og_title":"CureVac: Vaksina kund\u00ebr Coron\u00ebs e mundur n\u00eb vjesht\u00eb - Informohu qart\u00ebsisht!","og_description":"Nga vjeshta dhjet\u00ebra mij\u00ebra vet\u00eb mund t\u00eb marrin vaksin\u00ebn kund\u00ebr virusit Corona, sipas kreut t\u00eb firm\u00ebs bioteknologjike, CureVac n\u00eb Tybingen t\u00eb Gjermanis\u00eb, shkruan afp. Por ende ka pengesa. Kreu i firm\u00ebs bioteknologjike gjermane n\u00eb Tybingen, CureVac, Franz Werner Haas ka b\u00ebr\u00eb t\u00eb ditur, se nga vjeshta \u00ebsht\u00eb i mundur furnizimi i dhjet\u00ebra mij\u00ebra vet\u00ebve me […]","og_url":"https:\/\/redaktori.com\/?p=20333","og_site_name":"Informohu qart\u00ebsisht!","article_published_time":"2020-03-21T12:02:48+00:00","og_image":[{"width":892,"height":501,"url":"https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg","type":"image\/jpeg"}],"author":"http:\/\/redaktori.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"http:\/\/redaktori.com","Est. reading time":"2 minuta"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/redaktori.com\/?p=20333","url":"https:\/\/redaktori.com\/?p=20333","name":"CureVac: Vaksina kund\u00ebr Coron\u00ebs e mundur n\u00eb vjesht\u00eb - Informohu qart\u00ebsisht!","isPartOf":{"@id":"https:\/\/redaktori.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/redaktori.com\/?p=20333#primaryimage"},"image":{"@id":"https:\/\/redaktori.com\/?p=20333#primaryimage"},"thumbnailUrl":"https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg","datePublished":"2020-03-21T12:02:48+00:00","dateModified":"2020-03-21T12:02:48+00:00","author":{"@id":"https:\/\/redaktori.com\/#\/schema\/person\/470e9b98b348cb5da953e2daff276aa2"},"breadcrumb":{"@id":"https:\/\/redaktori.com\/?p=20333#breadcrumb"},"inLanguage":"sq","potentialAction":[{"@type":"ReadAction","target":["https:\/\/redaktori.com\/?p=20333"]}]},{"@type":"ImageObject","inLanguage":"sq","@id":"https:\/\/redaktori.com\/?p=20333#primaryimage","url":"https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg","contentUrl":"https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg","width":892,"height":501,"caption":"FILE PHOTO: An employee of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020. Picture taken on March 12, 2020. REUTERS\/Andreas Gebert\/File Photo"},{"@type":"BreadcrumbList","@id":"https:\/\/redaktori.com\/?p=20333#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/redaktori.com\/"},{"@type":"ListItem","position":2,"name":"CureVac: Vaksina kund\u00ebr Coron\u00ebs e mundur n\u00eb vjesht\u00eb"}]},{"@type":"WebSite","@id":"https:\/\/redaktori.com\/#website","url":"https:\/\/redaktori.com\/","name":"http:\/\/redaktori.com - Informohu qart\u00ebsisht!","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/redaktori.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sq"},{"@type":"Person","@id":"https:\/\/redaktori.com\/#\/schema\/person\/470e9b98b348cb5da953e2daff276aa2","name":"http:\/\/redaktori.com","image":{"@type":"ImageObject","inLanguage":"sq","@id":"https:\/\/redaktori.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5555287f41529e19277415e6cb9cfb4c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5555287f41529e19277415e6cb9cfb4c?s=96&d=mm&r=g","caption":"http:\/\/redaktori.com"}}]}},"jetpack_featured_media_url":"https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg","blog_post_layout_featured_media_urls":{"thumbnail":["https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac-150x150.jpg",150,150,true],"full":["https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg",892,501,false]},"categories_names":{"6":{"name":"Aktualitet","link":"https:\/\/redaktori.com\/?cat=6"},"3":{"name":"Kryesore","link":"https:\/\/redaktori.com\/?cat=3"},"20":{"name":"Rajon\/Bot\u00eb","link":"https:\/\/redaktori.com\/?cat=20"},"21":{"name":"Sociale","link":"https:\/\/redaktori.com\/?cat=21"}},"tags_names":[],"comments_number":"0","wpmagazine_modules_lite_featured_media_urls":{"thumbnail":["https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac-150x150.jpg",150,150,true],"cvmm-medium":["https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg",300,168,false],"cvmm-medium-plus":["https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg",305,171,false],"cvmm-portrait":["https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg",400,225,false],"cvmm-medium-square":["https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg",600,337,false],"cvmm-large":["https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg",892,501,false],"cvmm-small":["https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg",130,73,false],"full":["https:\/\/redaktori.com\/wp-content\/uploads\/2020\/03\/Cure-vac.jpg",892,501,false]},"_links":{"self":[{"href":"https:\/\/redaktori.com\/index.php?rest_route=\/wp\/v2\/posts\/20333"}],"collection":[{"href":"https:\/\/redaktori.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/redaktori.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/redaktori.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/redaktori.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20333"}],"version-history":[{"count":1,"href":"https:\/\/redaktori.com\/index.php?rest_route=\/wp\/v2\/posts\/20333\/revisions"}],"predecessor-version":[{"id":20335,"href":"https:\/\/redaktori.com\/index.php?rest_route=\/wp\/v2\/posts\/20333\/revisions\/20335"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/redaktori.com\/index.php?rest_route=\/wp\/v2\/media\/20334"}],"wp:attachment":[{"href":"https:\/\/redaktori.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/redaktori.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/redaktori.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}